Reference
Kramer R, et al. Cost and burden of RSV related hospitalisation from 2012 to 2017 in the first year of life in Lyon, France. Vaccine : 25 Sep 2018. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2018.09.029
Rights and permissions
About this article
Cite this article
Targeted prevention could reduce RSV costs in France. PharmacoEcon Outcomes News 814, 30 (2018). https://doi.org/10.1007/s40274-018-5373-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5373-5